Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Envafolimab and Lenvatinib with HAIC for Advanced Biliary Tract Cancer
NCT07636798Phase 2Recruiting
- Sponsor
- West China Hospital of Sichuan University
- Start
- Jun 2026
- Primary completion
- Mar 2029
- Countries
- 1
01
Overview
A Phase 2 trial of envafolimab, lenvatinib in biliary tract cancer (BTC), sponsored by West China Hospital of Sichuan University. Started Jun 2026; status: recruiting.
02
Drugs
envafolimablenvatinib
03
Conditions
biliary tract cancer (BTC)
Beyond the preview
Go deeper on NCT07636798.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07636798.